0001209191-22-024219.txt : 20220412
0001209191-22-024219.hdr.sgml : 20220412
20220412193651
ACCESSION NUMBER: 0001209191-22-024219
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220412
FILED AS OF DATE: 20220412
DATE AS OF CHANGE: 20220412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MILESON GLENNA
CENTRAL INDEX KEY: 0001822241
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39503
FILM NUMBER: 22823351
MAIL ADDRESS:
STREET 1: 4000 MASON ROAD, SUITE 300
STREET 2: BOX 352141
CITY: SEATTLE
STATE: WA
ZIP: 98195-2141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athira Pharma, Inc.
CENTRAL INDEX KEY: 0001620463
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 453368487
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18706 NORTH CREEK PARKWAY, SUITE 104
CITY: BOTHELL
STATE: WA
ZIP: 98011
BUSINESS PHONE: (425) 620-8501
MAIL ADDRESS:
STREET 1: 18706 NORTH CREEK PARKWAY, SUITE 104
CITY: BOTHELL
STATE: WA
ZIP: 98011
FORMER COMPANY:
FORMER CONFORMED NAME: M3 Biotechnology, Inc.
DATE OF NAME CHANGE: 20140924
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-04-12
0
0001620463
Athira Pharma, Inc.
ATHA
0001822241
MILESON GLENNA
C/O ATHIRA PHARMA, INC.
18706 NORTH CREEK PARKWAY, SUITE 104
BOTHELL
WA
98011
0
1
0
0
Chief Financial Officer
Common Stock
2022-04-11
4
M
0
3000
10.64
A
100060
D
Stock Option (right to buy)
10.64
2022-04-11
4
M
0
3000
0.00
D
2032-01-17
Common Stock
3000
167000
D
One forty-eighth (1/48th) of the shares subject to the option will vest on February 18, 2022, and one forty-eighth of the shares subject to the option will vest each month thereafter.
/s/ Glenna Mileson
2022-04-12